| 发明名称 | Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin | ||
| 摘要 | This invention relates to a co-crystal of vorapaxar and aspirin. The inventive co-crystal antagonizes the PAR-1 receptor. This invention also provides for pharmaceutical compositions comprising the inventive co-crystal as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by antagonizing the PAR-1 receptor. | ||
| 申请公布号 | US9604971(B2) | 申请公布日期 | 2017.03.28 |
| 申请号 | US201414905193 | 申请日期 | 2014.07.17 |
| 申请人 | ARALEZ PHARMACEUTICALS TRADING DAC | 发明人 | Trzaska Scott;Duran-Capece Alicia V.;Lamm Matthew |
| 分类号 | C07D405/06;A61K31/443;A61K31/616;C07C69/157 | 主分类号 | C07D405/06 |
| 代理机构 | Parker Highlander PLLC | 代理人 | Parker Highlander PLLC |
| 主权项 | 1. A co-crystal of vorapaxar and aspirin. | ||
| 地址 | Dublin IE | ||